跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确讨论反事实因果净获益、混杂调整及随机试验和观察研究中的治疗效应。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Torben Martinussen
Stijn Vansteelandt

删失事件时间数据中因果净获益的去偏学习

研究问题
生存分析中的风险比解释困难,现有净获益方法又面临模型误设或协变量调整限制;作者研究更灵活的因果净获益估计。
方法与思路
作者以反事实定义条件因果净获益标量,利用有效影响函数构造去偏估计量,并允许自适应学习治疗、生存及删失机制。
材料陈述的贡献
摘要称,该估计量具有根号样本量一致性,可通过协变量调整改善试验效率及处理混杂和删失,并提出效率界更有利的变体。
阅读关注点
应核对反事实净获益的定义、混杂和删失的识别条件、辅助函数学习要求,以及不同目标量之间的解释和效率权衡。
阅读边界
仅据所给 Crossref 摘要,不能将模型自由理解为无需识别假设;具体收敛条件、效率比较和乳腺癌应用结果未说明。

原文摘要

Summary Cox regression is the default approach to evaluating the (relative) effect of two treatments on a survival endpoint. This standard framework has nonetheless been criticized for its canonical effect measure, the hazard ratio, having a subtle interpretation, thereby hindering policy-making. This in turn has prompted interest in other effects measures, such as the difference in restricted mean survival time, the net benefit and the win ratio, which have become increasingly popular. Developments in estimation and inference for the net benefit and win ratio proceed either under a semiparametric model, at the risk of bias due to model misspecification, or in a nonparametric model, but without the flexibility to adjust for covariates. In this paper, we overcome these challenges by introducing a scalar, model-free measure of conditional causal net benefit in terms of counterfactuals and developing a debiased estimator based on its efficient influence function. This estimator is root-$ n $ consistent and asymptotically model-free by flexibly enabling data-adaptive learning (e.g., machine learning) of the dependence of treatment, survival and censoring time on baseline covariates. By incorporating such covariates, the proposed estimators can improve the efficiency of randomized trial analyses, as well as correct for confounding and censoring bias in both randomized and observational studies. We also propose variations of the considered estimand (and estimator) that have a more favourable efficiency bound. The proposed method is illustrated by simulation studies and analysis of breast cancer data.

笔记与分组